Martine Rothblatt sells $4.3 million in United Therapeutics shares
boldestvoice.com
United Therapeutics CEO Martine Rothblatt sold about $4.3 million in company stock, according to an SEC Form 4 insider filing.

The chief executive of United Therapeutics sold about $4.3 million worth of company stock, according to a federal insider trading filing.

0